Frank Jaschinski, Ph.D.
Frank is a distinguished expert in antisense oligonucleotide (ASO) discovery and development, with specialized knowledge in oncology and metabolic diseases. Throughout his career, he spearheaded the development of targeted ASO therapies and built valuable ASO pipelines. Frank's prior roles include scientific leadership at Antisense Pharma/Isarna Therapeutics and The Genetics Company.
As a respected member of the scientific and biopharmaceutical community, his contributions are celebrated at international forums and in top peer-reviewed journals. He earned his Ph.D. in Biochemistry from the University of Zurich, Switzerland.
